EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Autonomic Alterations After Pulmonary Vein Isolation or Antiarrhythmic Drug Therapy

Jason G Andrade, Tolga Aksu, Richard G Bennett, Fahmida Homayra, Sewanou Hermann Honfo, Martin Aguilar, Paul Khairy, Marc W Deyell, Laurent Macle

JACC: Clinical Electrophysiology · 2026

DOI: 10.1016/j.jacep.2026.04.025 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2026. Verfasst von Jason G Andrade und 8 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Heart Institute, Department of Medicine, Université de Montréal, Canada; Dilawri Cardiovascular Institute and Center for Cardiovascular Inno…. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Atrial Fibrillation, Autonomic Nervous System, Catheter Ablation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The natural history of autonomic alterations following catheter ablation or antiarrhythmic drug therapy is poorly defined, largely owing to reliance on noninvasive intermittent rhythm monitoring and lack of comparative trials. OBJECTIVES: This study sought to evaluate the impact of catheter ablation or pharmacologic rhythm control on long-term autonomic parameters. METHODS: This study included 303 patients with paroxysmal treatment-naïve atrial fibrillation enrolled in the EARLY-AF (Early Aggressive Invasive Intervention for Atrial Fibrillation) trial who were randomized to initial rhythm control therapy with cryoballoon ablation (154 patients) or antiarrhythmic drug therapy (149 patients). All patients underwent insertion of an implantable cardiac monitor (ICM) at trial enrollment. The ICM continuously recorded physical activity, heart rate variability (HRV; measured as the standard deviation of the average normal-to-normal), daytime heart rate (DHR), and nighttime heart rate (NHR). Longitudinal outcomes were analyzed using inverse probability-weighted mixed-effects models. RESULTS: At baseline there were no significant differences in HRV, DHR, and NHR between randomized groups. Over a median follow-up of 1,143 days (Q1-Q3: 1,084-1,270 days), there were significant differences in DHR, NHR, and HRV between patients randomized to catheter ablation and those randomized to antiarrhythmic drug therapy. Patients randomized to ablation had reduced HRV and greater DHR and NHR. Ablation was associated with lower HRV and higher DHR and NHR early after treatment, with differences persisting through 24 months for NHR and HRV and through 36 months for DHR. These parameters did not differ from baseline in those randomized to antiarrhythmic drug therapy, but patients crossing over from antiarrhythmic drug therapy to ablation exhibited autonomic parameters consistent with the treatment received. Post-treatment NHR and HRV were significantly associated with arrhythmia recurrence. CONCLUSIONS: Cryoballoon-based pulmonary vein isolation results in significant sustained changes in the heart rate parameters related to autonomic function, compared with those randomized to antiarrhythmic drug therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Arrhythmia AgentsAtrial FibrillationAutonomic Nervous SystemCatheter AblationPulmonary VeinsAgedFemaleHumansMaleMiddle AgedHeart RateTreatment Outcome

Stichwörter der Autor:innen

antiarrhythmic drug therapyautonomiccatheter ablationganglionated plexirhythm control

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Montreal Heart Institute, Department of Medicine, Université de Montréal, Canada; Dilawri Cardiovascular Institute and Center for Cardiovascular Innovation, Vancouver General Hospital, Vancouver, Canada; Department of M…
  • Yeditepe University Hospital, Istanbul, Turkey.
  • Dilawri Cardiovascular Institute and Center for Cardiovascular Innovation, Vancouver General Hospital, Vancouver, Canada; Department of Medicine, Vancouver General Hospital, Canada.
  • Dilawri Cardiovascular Institute and Center for Cardiovascular Innovation, Vancouver General Hospital, Vancouver, Canada.
  • Montreal Heart Institute, Department of Medicine, Université de Montréal, Canada.

Förderung

  • Medtronic

Zitieren

APA

Andrade, J. G., Aksu, T., Bennett, R. G., Homayra, F., Honfo, S. H., Aguilar, M., Khairy, P., Deyell, M. W., & Macle, L. (2026). Autonomic Alterations After Pulmonary Vein Isolation or Antiarrhythmic Drug Therapy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2026.04.025

Vancouver

Andrade JG, Aksu T, Bennett RG, Homayra F, Honfo SH, Aguilar M, et al. Autonomic Alterations After Pulmonary Vein Isolation or Antiarrhythmic Drug Therapy. JACC: Clinical Electrophysiology. 2026. doi:10.1016/j.jacep.2026.04.025

BibTeX
@article{Andrade2026,
  author = {Andrade, Jason G and Aksu, Tolga and Bennett, Richard G and Homayra, Fahmida and Honfo, Sewanou Hermann and Aguilar, Martin and Khairy, Paul and Deyell, Marc W and Macle, Laurent},
  title = {Autonomic Alterations After Pulmonary Vein Isolation or Antiarrhythmic Drug Therapy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  doi = {10.1016/j.jacep.2026.04.025}
}
Kostenlos starten →